Professor William Tarnow-Mordi

Professor of Neonatal Medicine, Sydney Medical School
Director, Neonatal and Perinatal Trials, NHMRC Clinical Trials Centre

Telephone +61 2 9845 7375

Map

Biographical details

“Your baby is very ill” – these are four words no parent ever wants to hear, and Professor William Tarnow-Mordi is working to help. He conducts international clinical trials to improve healthy outcomes in preterm or high-risk babies. Dr Tarnow-Mordi is Director of Neonatal and Perinatal Trials at the NHMRC Clinical Trials Centre (CTC) and Foundation Director of the WINNER Centre for Newborn Research at the University of Sydney. Professor Tarnow-Mordi completed his medical training at the University of Cambridge, UK, followed by specialist training in Paediatrics and Neonatal Medicine. He migrated to Australia in 1999 to commence an appointment as inaugural Professor of Neonatal Medicine, University of Sydney and Director of Neonatology, Westmead Hospital, where he led NSW’s busiest Neonatal department until 2010. Trials in extremely premature babies are challenging, and Dr Tarnow-Mordi and team are working to form global partnerships with clinicians, with the aim of finding cost-effective treatments that will reduce infant mortality and illness. The CTC’s Neonatal Research program focuses on areas of need, e.g. neonatal infection, oxygen therapy and simple cost-effective measures to reduce health problems and improve outcomes for high-risk newborn infants. His work has helped to improve survival rates in very preterm infants, influence clinical practice and achieve major health care cost savings worldwide by identifying ineffective treatments. Professor Tarnow-Mordi serves on the Steering Group of NSW Health’s Better Treatment for Kids Network and is co-chair of the Perinatal Society of Australia and New Zealand Clinical Trials Working Group.

Research interests

Professor Tarnow-Mordi leads and collaborates on large-scale, international multicentre randomised trials and cohort studies to improve outcomes for high-risk newborn infants. To date he has been involved in trials that have included >30,000 infants in >200 neonatal units worldwide. He is Principal Investigator of the BOOST II trial of 1,135 very preterm infants randomised to high vs low oxygen saturation targets during oxygen treatment, assessing death or major disability at 18-24 months after birth. He also has brought together Principal Investigators of four other similar international trials (the NeOProM Collaboration), who will conduct individual patient data analysis in 4,959 very preterm infants, to help resolve the long-standing uncertainty about appropriate oxygen saturations in infants of < 28 weeks gestation.

Professor Tarnow-Mordi is Principal Investigator of the Lactoferrin Evaluation in Anaemia in Pregnancy (LEAP-1) trial, which addresses the question of whether iron deficiency anaemia of pregnancy should be treated with lactoferrin. The study will compare the effects of supplementation with standard iron sulphate vs oral bovine lactoferrin in iron deficiency anaemia in pregnancy, on fetal growth (birth weight for gestational age) and neonatal iron status at birth. Additionally, he co-chairs the Australian Placental Transfusion Study, which is assessing whether a 60-second delay in clamping and cutting the cord can improve blood flow to the brain and gut and reduce death and disability in babies born more than 10 weeks early.

Selected grants

2015

  • TORPIDO2- Targeted Oxygen for Resuscitation of Preterm Infants effects on Developmental Outcomes 2; Oei J, Tarnow-Mordi W, Lui K, Finer N, Saugstad O, Vento M, Buonocore G, Marlow N; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Does placental transfusion prevent death and disability in very preterm infants Childhood follow up in the NHMRC Australian Placental Transfusion Study.; Tarnow-Mordi W, Lui K, Kluckow M, Duley L, Marlow N; National Health and Medical Research Council (NHMRC)/Project Grants.

2014

  • Should we treat iron deficiency anaemia of pregnancy with lactoferrin A randomised controlled trial; Tarnow-Mordi W, Dibley M, Norman J, Reynolds R, Callander E; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • Does bovine lactoferrin (bLF) reduce mortality and morbidity in very low birthweight infants; Tarnow-Mordi W, Soll R, Manzoni P, Darlow B, Isaacs D, Lui K, Schofield D, Wilkinson D, Martin A, Hague W; National Health and Medical Research Council (NHMRC)/Project Grants.

2011

  • Two day workshop to plan a programme of collaborative laboratory and clinical research on the role of bovine lactoferrin to prevent prematurity, neonatal sepsis and mortality; Tarnow-Mordi W, Dibley M, Ghadge A, Isaacs D, Sebastian L, Kumar P; Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education (Fed)/Australia-India Strategic Research Fund (AISRF).

2009

  • Should very premature babies receive a placental transfusion at birth A randomised controlled trial.; Tarnow-Mordi W, Morris J, Newnham J, Hague W, Forder P, Kluckow M, Evans N, Newnham J, Osborn D, Isaacs D; National Health and Medical Research Council (NHMRC)/Project Grants.

2005

  • Which oxygen saturation level should we use for very premature infants? A randomised controlled trial; Tarnow-Mordi W, Cole C, Askie L, Morley J, Doyle L, Davis P, Cole C; National Health and Medical Research Council (NHMRC)/Project Grants.

2004

  • International neonatal immunotherapy study (INIS): a randomised trial of intravenous immunoglobulin for neonatal sepsis; Tarnow-Mordi W, Henderson-Smart D, Hague W, Isaacs D; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • International neonatal immunotherapy study (INIS): a randomised trail of intravenous immunoglobulin for neonatal sepsis; Tarnow-Mordi W; DVC Research/Bridging Support Grant.
  • International neonatal immunotherapy study (INIS); Tarnow-Mordi W; Telstra Foundation/Research Grant.

2002

  • Shared Grant MRC UK G9900825, Grant ID: ID50733, admin University of Oxford. International neonatal immunotherapu study: a randomised trial of intravenous immunoglobulin (IVIG) for neonatal sepsis.; Tarnow-Mordi W, Brocklehurst P, Haque K, Brocklehurst P; UK Medical Research Council (MRC UK)/Research Grant.
  • International neonatal immunotherapy study: a randomised trial of intravenous immunoglobin(IVIG) for neonatal sepsis; Tarnow-Mordi W; The Financial Markets Foundation for Children/Financial Markets Foundation for Children Research Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Tarnow-Mordi, W. (2015). Reply. American Journal of Obstetrics & Gynecology, 212(6), 828-829. [More Information]
  • Tarnow-Mordi, W., Soll, R. (2014). Probiotic supplementation in preterm infants: it is time to change practice. The Journal of Pediatrics, 164(5), 959-960. [More Information]
  • Darlow, B., Marschner, S., Donoghoe, M., Battin, M., Broadbent, R., Elder, M., Hewson, M., Meyer, M., Ghadge, A., Graham, P., Tarnow-Mordi, W., et al (2014). Randomized Controlled Trial of Oxygen Saturation Targets in Very Preterm Infants: Two Year Outcomes. The Journal of Pediatrics, 165(1), 30-35.e2. [More Information]
  • Tarnow-Mordi, W., Duley, L., Field, D., Marlow, N., Morris, J., Newnham, J., Paneth, N., Soll, R., Sweet, D. (2014). Timing of cord clamping in very preterm infants: more evidence is needed. American Journal of Obstetrics & Gynecology, 211(2), 118-123. [More Information]
  • Jacobs, S., Berg, M., Hunt, R., Tarnow-Mordi, W., Inder, T., Davis, P. (2013). Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews, 2013 (1), 1-112. [More Information]
  • Stenson, B., Tarnow-Mordi, W., Darlow, B., Simes, R., Juszczak, E., Askie, L., Battin, M., Bowler, U., Broadbent, R., Cairns, P., Donoghoe, M., Ghadge, A., Hague, W., Kirby, A., et al (2013). Oxygen Saturation and Outcomes in Preterm Infants. The New England Journal of Medicine, 368(22), 2094-2104. [More Information]
  • Martin, A., Darlow, B., Salt, A., Hague, W., Sebastian, L., Mceill, N., Tarnow-Mordi, W. (2013). Performance of the Parent Report of Children's Abilities-Revised (PARCA-R) versus the Bayley Scales of Infant Development III. Archives of Disease in Childhood, 98(12), 955-958. [More Information]
  • Tarnow-Mordi, W., Simes, R., Cruz, M. (2013). Strategies to accelerate recruitment to NHMRC multi-centre clinical trials. Journal of Paediatrics and Child Health, 49(1), e103-e105. [More Information]
  • Wilkinson, D., Gerrand, N., Cruz, M., Tarnow-Mordi, W. (2013). The "research misconception" and the SUPPORT trial: toward evidence-based consensus. The American Journal of Bioethics, 13(12), 48-50. [More Information]
  • Wilfond, B., Magnus, D., Antommaria, A., Appelbaum, P., Aschner, J., Barrington, K., Beauchamp, T., Boss, R., Burke, W., Caplan, A., Tarnow-Mordi, W., et al (2013). The OHRP and SUPPORT. The New England Journal of Medicine, 368(25), e36.1-e36.3. [More Information]
  • Tarnow-Mordi, W., Cruz, M., Wilkinson, D. (2012). Evaluating therapeutic hypothermia: parental perspectives should be explicitly represented in future research. Archives of Pediatrics & Adolescent Medicine, 166(6), 578-579. [More Information]
  • Tarnow-Mordi, W., Cruz, M. (2012). Evidence-based neonatal medicine in Latin America: what can we learn from the International Neonatal Immunotherapy Study and trials of IVIg? Jornal de Pediatria: the official journal of the Brazilian Pediatric Society, 88(5), 369-371. [More Information]
  • Martin, A., Darlow, B., Salt, A., Hague, W., Sebastian, L., Mann, K., Tarnow-Mordi, W. (2012). Identification of infants with major cognitive delay using parental report. Developmental Medicine and Child Neurology, 54(3), 254-259. [More Information]
  • Koh, J., Yeo, C., Wright, I., Lui, K., Saugstad, O., Tarnow-Mordi, W., Smyth, J., Oei, J. (2012). The use of oxygen for delivery room resuscitation of newborn infants in non-Western countries. Early Human Development, 88(8), 631-635. [More Information]
  • Stenson, B., Brocklehurst, P., Tarnow-Mordi, W. (2011). Increased 36-week survival with high oxygen saturation target in extremely preterm infants. The New England Journal of Medicine, 364(17), 1680-1682. [More Information]
  • Tarnow-Mordi, W., Kumar, P., Kler, N. (2011). Intrauterine contraception: why are so few Australian women using this effective method? Acta Paediatrica. [More Information]
  • Tarnow-Mordi, W., Wilkinson, D., Trivedi, A. (2011). Necrotizing Enterocolitis. The New England Journal of Medicine, 364(19), 1877-1878. [More Information]
  • Tarnow-Mordi, W., Kumar, P., Kler, N. (2011). Need for larger trials in pediatric critical care and neonatal medicine. Acta Paediatrica: Nurturing the Child, 100(5), 637-637. [More Information]
  • Tarnow-Mordi, W., Kumar, P., Kler, N. (2011). Neonatal trials need thousands, not hundreds, to change global practice. Acta Paediatrica: Nurturing the Child, 100(3), 330-333. [More Information]
  • Askie, L., Brocklehurst, P., Darlow, B., Finer, N., Schmidt, B., Tarnow-Mordi, W. (2011). NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatrics, 11, A6-1-A6-9. [More Information]
  • Manzoni, P., Rizzollo, S., Vain, N., Mostert, M., Stronati, M., Tarnow-Mordi, W., Farina, D. (2011). Probiotics use in preterm neonates: what further evidence is needed? Early Human Development, 87(Suppl 1), s3-s4. [More Information]
  • Tarnow-Mordi, W., Evans, N., Lui, K., Darlow, B. (2011). Risk of brain damage in babies from naphthalene in mothballs: call to consider a national ban. Medical Journal of Australia, 194(3), 150-150. [More Information]
  • Brocklehurst, P., Farrell, B., King, A., Juszczak, E., Darlow, B., Haque, K., Salt, A., Stenson, B., Tarnow-Mordi, W. (2011). Treatment of neonatal sepsis with intravenous immune globulin. The New England Journal of Medicine, 365(13), 1201-1211. [More Information]
  • Tarnow-Mordi, W., Isaacs, D., Dutta, S. (2010). Adjunctive Immunologic Interventions in Neonatal Sepsis. Clinics in Perinatology, 37(2), 481-499. [More Information]
  • Manzoni, P., Tarnow-Mordi, W., Franco, C., Gallo, E., Spera, A., Rizzollo, S., Decembrino, L., Stronati, M., Lanari, M., Farina, D., et al (2010). Clinical use of lactoferrin in preterm neonates: an update. Minerva Pediatrica, 62(3), 101-4. [More Information]
  • Tarnow-Mordi, W., Wilkinson, D., Trivedi, A., Brok, J. (2010). Probiotics Reduce All-Cause Mortality and Necrotizing Enterocolitis: It Is Time to Change Practice. Pediatrics, 125(5), 1068-70. [More Information]
  • Tarnow-Mordi, W., Gebski, V. (2010). Procalcitonin in intensive care units: the PRORATA trial. The Lancet, 375(9726), 1605. [More Information]
  • Tarnow-Mordi, W., Wilkinson, D., Trivedi, A., Sinn, J., Dutta, S., Parikh, T., Lin, H. (2010). Re: ESPGHAN Commentary and Education That Probiotics Substantially Reduce All-cause Mortality and Necrotizing Enterocolitis in Preterm Infants. Journal of Pediatric Gastroenterology and Nutrition, 50(6), 694. [More Information]
  • Tarnow-Mordi, W., Darlow, B., Doyle, L. (2010). Target ranges of oxygen saturation in extremely preterm infants. The New England Journal of Medicine, 363(13), 1285; author reply 1285-6. [More Information]
  • Jacobs, S., Tarnow-Mordi, W. (2010). Therapeutic hypothermia for newborn infants with hypoxic-ischaemic encephalopathy. Journal of Paediatrics and Child Health, 46(10), 568-576. [More Information]
  • Field, D., Bajuk, B., Manktelow, B., Vincent, T., Dorling, J., Tarnow-Mordi, W., Draper, E., Henderson-Smart, D. (2008). Geographically based investigation of the influence of very-preterm births on routine mortality statistics from the UK and Australia. Archives of Disease in Childhood. Fetal and Neonatal Edition (e ADC - F and N), 93(3), F212-F216. [More Information]
  • Brocklehurst, P., Brearley, S., Haque, K., Leslie, A., Salt, A., Stenson, B., Stephenson, J., Tarnow-Mordi, W. (2008). The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial. BMC Pregnancy and Childbirth, 8(52), 52-1-52-13. [More Information]
  • Hamilton, K., Redshaw, M., Tarnow-Mordi, W. (2007). Nurse staffing in relation to risk-adjusted mortality in neonatal care. Archives of Disease in Childhood. Fetal and Neonatal Edition (e ADC - F and N), 92(2), 99-103.
  • Spence, K., Tarnow-Mordi, W., Duncan, G., Jayasuryia, N., Elliot, J., King, J., Kite, F. (2006). Measuring nursing workload in neonatal intensive care. Journal of Nursing Management, 14(3), 227-234. [More Information]
  • Profit, J., Zupancic, J., McCormick, M., Richardson, D., Escobar, G., Tucker, J., Tarnow-Mordi, W., Parry, G. (2006). Moderately premature infants at Kaiser Permanente Medical Care Program in California are discharged home earlier than their peers in Massachusetts and the United Kingdom. Archives of Disease in Childhood. Fetal and Neonatal Edition (e ADC - F and N), 91(4), 245-250.
  • Isaacs, D., Kilham, H., Gordon, A., Jeffery, H., Tarnow-Mordi, W., Woolnough, J., Hamblin, J., Tobin, B. (2006). Withdrawal of neonatal mechanical ventilation against the parents' wishes. Journal of Paediatrics and Child Health, 42, 311-315. [More Information]
  • Parry, G., Tucker, J., Tarnow-Mordi, W. (2005). Relationship between probable nosocomial bacteraemia and organisational and structural factors in UK neonatal intensive care units. BMJ Quality and Safety, 14(4), 264-269. [More Information]
  • Tarnow-Mordi, W. (2005). Right to die"..but context of limited resources can be encountered in developed countries too.". BMJ (online), 330(7504), 1389; discussion 1389. [More Information]
  • Gilbert, R., Pike, K., Kenyon, S., Tarnow-Mordi, W., Taylor, D. (2005). The effect of prepartum antibiotics on the type of neonatal bacteraemia: insights from the MRC ORACLE trials. BJOG: an international journal of obstetrics and gynaecology, 112(6), 830-832. [More Information]
  • Tarnow-Mordi, W. (2005). What have we learned about randomized, controlled trials in neonatal sepsis? Pediatric Critical Care Medicine, 6(3 Suppl), S146-S149. [More Information]
  • Tarnow-Mordi, W. (2005). What is the role of neonatal organ dysfunction and illness severity scores in therapeutic studies in sepsis? Pediatric Critical Care Medicine, 6(3 Suppl), S135-S137. [More Information]
  • Broughton, S., Berry, A., Jacobe, S., Cheeseman, P., Tarnow-Mordi, W., Greenough, A. (2004). An Illness Severity Score And Neonatal Mortality In Retrieved Neonates. European Journal of Pediatrics, 163(7), 385-389.
  • Mohan, P., Tarnow-Mordi, W., Stenson, B., Brokelhurst, P., Haque, K., Cavendish, V., Cust, A. (2004). Can Polyclonal Intravenous Immunoglobulin Limit Cytokine Mediated Cerebral Damage And Chronic Lung Disease In Preterm Infants? Archives of Disease in Childhood. Fetal and Neonatal Edition (e ADC - F and N), 89(1), F5-F8. [More Information]
  • Tarnow-Mordi, W., Gebski, V., Cust, A. (2004). Noninvasive Ventilation: To the Editor. New England Journal of Medicine, 351(12), 1257-1257. [More Information]
  • Broughton, S., Berry, A., Jacobe, S., Cheeseman, P., Tarnow-Mordi, W., Greenough, A. (2004). The Mortality Index For Neonatal Transportation Score: A New Mortality Prediction Model For Retrieved Neonates. Pediatrics, 114(4), e424-e428.
  • Tarnow-Mordi, W., Cust, A., Brocklehurst, P., Gates, S. (2003). Clinical trials for tomorrow funded by the MRC. BMJ: British Medical Journal, Online(13 August 2003).
  • Parry, G., Tucker, J., Tarnow-Mordi, W. (2003). CRIB II: an update of the clinical risk index for babies score. The Lancet, 361(9371), 1789-1791.
  • Tarnow-Mordi, W., Isaacs, D., Gilbert, G., Athayde, N., Stanley, F. (2003). Effect of oral clindamycin on late miscarriage and preterm delivery. The Lancet, 361(9375), 2161-2161.
  • Cole, C., Wright, K., Tarnow-Mordi, W., Phelps, D. (2003). Resolving Our Uncertainty About Oxygen Therapy. Pediatrics, 112(6), 1415-1419.
  • Lloyd, J., Askie, L., Smith, J., Tarnow-Mordi, W. (2003). Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity. Cochrane Database of Systematic Reviews, 2003 (2), 1-30.
  • Paradisis, M., Tarnow-Mordi, W., Athayde, N., Badawi, N. (2002). Congenital paraplegia. A complication of multifetal pregnancy reduction? BJOG: an international journal of obstetrics and gynaecology, 109(5), 582-584.

2015

  • Tarnow-Mordi, W. (2015). Reply. American Journal of Obstetrics & Gynecology, 212(6), 828-829. [More Information]

2014

  • Tarnow-Mordi, W., Soll, R. (2014). Probiotic supplementation in preterm infants: it is time to change practice. The Journal of Pediatrics, 164(5), 959-960. [More Information]
  • Darlow, B., Marschner, S., Donoghoe, M., Battin, M., Broadbent, R., Elder, M., Hewson, M., Meyer, M., Ghadge, A., Graham, P., Tarnow-Mordi, W., et al (2014). Randomized Controlled Trial of Oxygen Saturation Targets in Very Preterm Infants: Two Year Outcomes. The Journal of Pediatrics, 165(1), 30-35.e2. [More Information]
  • Tarnow-Mordi, W., Duley, L., Field, D., Marlow, N., Morris, J., Newnham, J., Paneth, N., Soll, R., Sweet, D. (2014). Timing of cord clamping in very preterm infants: more evidence is needed. American Journal of Obstetrics & Gynecology, 211(2), 118-123. [More Information]

2013

  • Jacobs, S., Berg, M., Hunt, R., Tarnow-Mordi, W., Inder, T., Davis, P. (2013). Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews, 2013 (1), 1-112. [More Information]
  • Stenson, B., Tarnow-Mordi, W., Darlow, B., Simes, R., Juszczak, E., Askie, L., Battin, M., Bowler, U., Broadbent, R., Cairns, P., Donoghoe, M., Ghadge, A., Hague, W., Kirby, A., et al (2013). Oxygen Saturation and Outcomes in Preterm Infants. The New England Journal of Medicine, 368(22), 2094-2104. [More Information]
  • Martin, A., Darlow, B., Salt, A., Hague, W., Sebastian, L., Mceill, N., Tarnow-Mordi, W. (2013). Performance of the Parent Report of Children's Abilities-Revised (PARCA-R) versus the Bayley Scales of Infant Development III. Archives of Disease in Childhood, 98(12), 955-958. [More Information]
  • Tarnow-Mordi, W., Simes, R., Cruz, M. (2013). Strategies to accelerate recruitment to NHMRC multi-centre clinical trials. Journal of Paediatrics and Child Health, 49(1), e103-e105. [More Information]
  • Wilkinson, D., Gerrand, N., Cruz, M., Tarnow-Mordi, W. (2013). The "research misconception" and the SUPPORT trial: toward evidence-based consensus. The American Journal of Bioethics, 13(12), 48-50. [More Information]
  • Wilfond, B., Magnus, D., Antommaria, A., Appelbaum, P., Aschner, J., Barrington, K., Beauchamp, T., Boss, R., Burke, W., Caplan, A., Tarnow-Mordi, W., et al (2013). The OHRP and SUPPORT. The New England Journal of Medicine, 368(25), e36.1-e36.3. [More Information]

2012

  • Tarnow-Mordi, W., Cruz, M., Wilkinson, D. (2012). Evaluating therapeutic hypothermia: parental perspectives should be explicitly represented in future research. Archives of Pediatrics & Adolescent Medicine, 166(6), 578-579. [More Information]
  • Tarnow-Mordi, W., Cruz, M. (2012). Evidence-based neonatal medicine in Latin America: what can we learn from the International Neonatal Immunotherapy Study and trials of IVIg? Jornal de Pediatria: the official journal of the Brazilian Pediatric Society, 88(5), 369-371. [More Information]
  • Martin, A., Darlow, B., Salt, A., Hague, W., Sebastian, L., Mann, K., Tarnow-Mordi, W. (2012). Identification of infants with major cognitive delay using parental report. Developmental Medicine and Child Neurology, 54(3), 254-259. [More Information]
  • Koh, J., Yeo, C., Wright, I., Lui, K., Saugstad, O., Tarnow-Mordi, W., Smyth, J., Oei, J. (2012). The use of oxygen for delivery room resuscitation of newborn infants in non-Western countries. Early Human Development, 88(8), 631-635. [More Information]

2011

  • Stenson, B., Brocklehurst, P., Tarnow-Mordi, W. (2011). Increased 36-week survival with high oxygen saturation target in extremely preterm infants. The New England Journal of Medicine, 364(17), 1680-1682. [More Information]
  • Tarnow-Mordi, W., Kumar, P., Kler, N. (2011). Intrauterine contraception: why are so few Australian women using this effective method? Acta Paediatrica. [More Information]
  • Tarnow-Mordi, W., Wilkinson, D., Trivedi, A. (2011). Necrotizing Enterocolitis. The New England Journal of Medicine, 364(19), 1877-1878. [More Information]
  • Tarnow-Mordi, W., Kumar, P., Kler, N. (2011). Need for larger trials in pediatric critical care and neonatal medicine. Acta Paediatrica: Nurturing the Child, 100(5), 637-637. [More Information]
  • Tarnow-Mordi, W., Kumar, P., Kler, N. (2011). Neonatal trials need thousands, not hundreds, to change global practice. Acta Paediatrica: Nurturing the Child, 100(3), 330-333. [More Information]
  • Askie, L., Brocklehurst, P., Darlow, B., Finer, N., Schmidt, B., Tarnow-Mordi, W. (2011). NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatrics, 11, A6-1-A6-9. [More Information]
  • Manzoni, P., Rizzollo, S., Vain, N., Mostert, M., Stronati, M., Tarnow-Mordi, W., Farina, D. (2011). Probiotics use in preterm neonates: what further evidence is needed? Early Human Development, 87(Suppl 1), s3-s4. [More Information]
  • Tarnow-Mordi, W., Evans, N., Lui, K., Darlow, B. (2011). Risk of brain damage in babies from naphthalene in mothballs: call to consider a national ban. Medical Journal of Australia, 194(3), 150-150. [More Information]
  • Brocklehurst, P., Farrell, B., King, A., Juszczak, E., Darlow, B., Haque, K., Salt, A., Stenson, B., Tarnow-Mordi, W. (2011). Treatment of neonatal sepsis with intravenous immune globulin. The New England Journal of Medicine, 365(13), 1201-1211. [More Information]

2010

  • Tarnow-Mordi, W., Isaacs, D., Dutta, S. (2010). Adjunctive Immunologic Interventions in Neonatal Sepsis. Clinics in Perinatology, 37(2), 481-499. [More Information]
  • Manzoni, P., Tarnow-Mordi, W., Franco, C., Gallo, E., Spera, A., Rizzollo, S., Decembrino, L., Stronati, M., Lanari, M., Farina, D., et al (2010). Clinical use of lactoferrin in preterm neonates: an update. Minerva Pediatrica, 62(3), 101-4. [More Information]
  • Tarnow-Mordi, W., Wilkinson, D., Trivedi, A., Brok, J. (2010). Probiotics Reduce All-Cause Mortality and Necrotizing Enterocolitis: It Is Time to Change Practice. Pediatrics, 125(5), 1068-70. [More Information]
  • Tarnow-Mordi, W., Gebski, V. (2010). Procalcitonin in intensive care units: the PRORATA trial. The Lancet, 375(9726), 1605. [More Information]
  • Tarnow-Mordi, W., Wilkinson, D., Trivedi, A., Sinn, J., Dutta, S., Parikh, T., Lin, H. (2010). Re: ESPGHAN Commentary and Education That Probiotics Substantially Reduce All-cause Mortality and Necrotizing Enterocolitis in Preterm Infants. Journal of Pediatric Gastroenterology and Nutrition, 50(6), 694. [More Information]
  • Tarnow-Mordi, W., Darlow, B., Doyle, L. (2010). Target ranges of oxygen saturation in extremely preterm infants. The New England Journal of Medicine, 363(13), 1285; author reply 1285-6. [More Information]
  • Jacobs, S., Tarnow-Mordi, W. (2010). Therapeutic hypothermia for newborn infants with hypoxic-ischaemic encephalopathy. Journal of Paediatrics and Child Health, 46(10), 568-576. [More Information]

2008

  • Field, D., Bajuk, B., Manktelow, B., Vincent, T., Dorling, J., Tarnow-Mordi, W., Draper, E., Henderson-Smart, D. (2008). Geographically based investigation of the influence of very-preterm births on routine mortality statistics from the UK and Australia. Archives of Disease in Childhood. Fetal and Neonatal Edition (e ADC - F and N), 93(3), F212-F216. [More Information]
  • Brocklehurst, P., Brearley, S., Haque, K., Leslie, A., Salt, A., Stenson, B., Stephenson, J., Tarnow-Mordi, W. (2008). The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial. BMC Pregnancy and Childbirth, 8(52), 52-1-52-13. [More Information]

2007

  • Hamilton, K., Redshaw, M., Tarnow-Mordi, W. (2007). Nurse staffing in relation to risk-adjusted mortality in neonatal care. Archives of Disease in Childhood. Fetal and Neonatal Edition (e ADC - F and N), 92(2), 99-103.

2006

  • Spence, K., Tarnow-Mordi, W., Duncan, G., Jayasuryia, N., Elliot, J., King, J., Kite, F. (2006). Measuring nursing workload in neonatal intensive care. Journal of Nursing Management, 14(3), 227-234. [More Information]
  • Profit, J., Zupancic, J., McCormick, M., Richardson, D., Escobar, G., Tucker, J., Tarnow-Mordi, W., Parry, G. (2006). Moderately premature infants at Kaiser Permanente Medical Care Program in California are discharged home earlier than their peers in Massachusetts and the United Kingdom. Archives of Disease in Childhood. Fetal and Neonatal Edition (e ADC - F and N), 91(4), 245-250.
  • Isaacs, D., Kilham, H., Gordon, A., Jeffery, H., Tarnow-Mordi, W., Woolnough, J., Hamblin, J., Tobin, B. (2006). Withdrawal of neonatal mechanical ventilation against the parents' wishes. Journal of Paediatrics and Child Health, 42, 311-315. [More Information]

2005

  • Parry, G., Tucker, J., Tarnow-Mordi, W. (2005). Relationship between probable nosocomial bacteraemia and organisational and structural factors in UK neonatal intensive care units. BMJ Quality and Safety, 14(4), 264-269. [More Information]
  • Tarnow-Mordi, W. (2005). Right to die"..but context of limited resources can be encountered in developed countries too.". BMJ (online), 330(7504), 1389; discussion 1389. [More Information]
  • Gilbert, R., Pike, K., Kenyon, S., Tarnow-Mordi, W., Taylor, D. (2005). The effect of prepartum antibiotics on the type of neonatal bacteraemia: insights from the MRC ORACLE trials. BJOG: an international journal of obstetrics and gynaecology, 112(6), 830-832. [More Information]
  • Tarnow-Mordi, W. (2005). What have we learned about randomized, controlled trials in neonatal sepsis? Pediatric Critical Care Medicine, 6(3 Suppl), S146-S149. [More Information]
  • Tarnow-Mordi, W. (2005). What is the role of neonatal organ dysfunction and illness severity scores in therapeutic studies in sepsis? Pediatric Critical Care Medicine, 6(3 Suppl), S135-S137. [More Information]

2004

  • Broughton, S., Berry, A., Jacobe, S., Cheeseman, P., Tarnow-Mordi, W., Greenough, A. (2004). An Illness Severity Score And Neonatal Mortality In Retrieved Neonates. European Journal of Pediatrics, 163(7), 385-389.
  • Mohan, P., Tarnow-Mordi, W., Stenson, B., Brokelhurst, P., Haque, K., Cavendish, V., Cust, A. (2004). Can Polyclonal Intravenous Immunoglobulin Limit Cytokine Mediated Cerebral Damage And Chronic Lung Disease In Preterm Infants? Archives of Disease in Childhood. Fetal and Neonatal Edition (e ADC - F and N), 89(1), F5-F8. [More Information]
  • Tarnow-Mordi, W., Gebski, V., Cust, A. (2004). Noninvasive Ventilation: To the Editor. New England Journal of Medicine, 351(12), 1257-1257. [More Information]
  • Broughton, S., Berry, A., Jacobe, S., Cheeseman, P., Tarnow-Mordi, W., Greenough, A. (2004). The Mortality Index For Neonatal Transportation Score: A New Mortality Prediction Model For Retrieved Neonates. Pediatrics, 114(4), e424-e428.

2003

  • Tarnow-Mordi, W., Cust, A., Brocklehurst, P., Gates, S. (2003). Clinical trials for tomorrow funded by the MRC. BMJ: British Medical Journal, Online(13 August 2003).
  • Parry, G., Tucker, J., Tarnow-Mordi, W. (2003). CRIB II: an update of the clinical risk index for babies score. The Lancet, 361(9371), 1789-1791.
  • Tarnow-Mordi, W., Isaacs, D., Gilbert, G., Athayde, N., Stanley, F. (2003). Effect of oral clindamycin on late miscarriage and preterm delivery. The Lancet, 361(9375), 2161-2161.
  • Cole, C., Wright, K., Tarnow-Mordi, W., Phelps, D. (2003). Resolving Our Uncertainty About Oxygen Therapy. Pediatrics, 112(6), 1415-1419.
  • Lloyd, J., Askie, L., Smith, J., Tarnow-Mordi, W. (2003). Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity. Cochrane Database of Systematic Reviews, 2003 (2), 1-30.

2002

  • Paradisis, M., Tarnow-Mordi, W., Athayde, N., Badawi, N. (2002). Congenital paraplegia. A complication of multifetal pregnancy reduction? BJOG: an international journal of obstetrics and gynaecology, 109(5), 582-584.

To update your profile click here. For support on your academic profile contact .